Related references
Note: Only part of the references are listed.Alternative splicing of Ikaros regulates the FUT4/LeX-α5β1 integrin-FAK axis in acute lymphoblastic leukemia
Lijun Yi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma
Rocco Sciarrillo et al.
EBIOMEDICINE (2019)
The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome
Yi-Tsung Yang et al.
BLOOD CANCER JOURNAL (2018)
Aberrant splicing in B-cell acute lymphoblastic leukemia
Kathryn L. Black et al.
NUCLEIC ACIDS RESEARCH (2018)
Exons of Leukemia Suppressor Genes: Creative Assembly Required
Mukta Asnani et al.
TRENDS IN CANCER (2018)
Clinical significance of the ABCB1 and ABCG2 gene expression levels in acute lymphoblastic leukemia
I. Olarte Carrillo et al.
HEMATOLOGY (2017)
JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias
C. Delgado-Martin et al.
LEUKEMIA (2017)
Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma
S-K Leivonen et al.
BLOOD CANCER JOURNAL (2017)
Shift in energy metabolism caused by glucocorticoids enhances the effect of cytotoxic anti-cancer drugs against acute lymphoblastic leukemia cells
Shigeki Aoki et al.
ONCOTARGET (2017)
Folylpolyglutamate synthetase splicing alterations in acute lymphoblastic leukemia are provoked by methotrexate and other chemotherapeutics and mediate chemoresistance
Anna Wojtuszkiewicz et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Tumor suppressor IKZF1 mediates glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia
R. Marke et al.
LEUKEMIA (2016)
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
Zuguang Gu et al.
BIOINFORMATICS (2016)
The association of aberrant folylpolyglutamate synthetase splicing with ex vivo methotrexate resistance and clinical outcome in childhood acute lymphoblastic leukemia
Anna Wojtuszkiewicz et al.
HAEMATOLOGICA (2016)
Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group
Rob Pieters et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins
Stanley Chun-Wei Lee et al.
NATURE MEDICINE (2016)
g:Profiler-a web server for functional interpretation of gene lists (2016 update)
Juri Reimand et al.
NUCLEIC ACIDS RESEARCH (2016)
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
Hsin-An Hou et al.
ONCOTARGET (2016)
The association of aberrant folylpolyglutamate synthetase splicing with ex vivo methotrexate resistance and clinical outcome in childhood acute lymphoblastic leukemia
Anna Wojtuszkiewicz et al.
HAEMATOLOGICA (2016)
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Rocco Sciarrillo et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2016)
MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia
Courtney L. Jones et al.
BLOOD (2015)
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
Ching-Hon Pui et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The spliceosome is a therapeutic vulnerability in MYC-driven cancer
Tiffany Y. -T. Hsu et al.
NATURE (2015)
MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis
Cheryl M. Koh et al.
NATURE (2015)
Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance
Anna Wojtuszkiewicz et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
Modulation of p53β and p53γ expression by regulating the alternative splicing of TP53 gene modifies cellular response
V. Marcel et al.
CELL DEATH AND DIFFERENTIATION (2014)
Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A
Christopher G. Hubert et al.
GENES & DEVELOPMENT (2013)
Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitors
Denise Niewerth et al.
HAEMATOLOGICA (2013)
Mutational analysis of splicing machinery genes SF3B1, U2AF1 and SRSF2 in myelodysplasia and other common tumors
Eun Mi Je et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Relapsed childhood acute lymphoblastic leukaemia
Deepa Bhojwani et al.
LANCET ONCOLOGY (2013)
Software for Computing and Annotating Genomic Ranges
Michael Lawrence et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Exploring the Molecular Mechanisms of Glucocorticoid Receptor Action from Sensitivity to Resistance
Sivapriya Ramamoorthy et al.
HORMONE RESISTANCE AND HYPERSENSITIVITY: FROM GENETICS TO CLINICAL MANAGEMENT (2013)
The spliceosome as a target of novel antitumour drugs
Sophie Bonnal et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Chronic Lymphocytic Leukemia with SF3B1 Mutation
Victor Quesada et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Alternative splicing networks regulated by signaling in human T cells
Nicole M. Martinez et al.
RNA (2012)
Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies
Laura E. Hogan et al.
BLOOD (2011)
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness
Davide Rossi et al.
BLOOD (2011)
Regulation of alternative splicing by the core spliceosomal machinery
Arneet L. Saltzman et al.
GENES & DEVELOPMENT (2011)
Transcriptomes of the B and T Lineages Compared by Multiplatform Microarray Profiling
Michio W. Painter et al.
JOURNAL OF IMMUNOLOGY (2011)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
E. Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2011)
Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia
Ronald W. Stam et al.
BLOOD (2010)
Long-Term Outcome in Children With Relapsed Acute Lymphoblastic Leukemia After Time-Point and Site-of-Relapse Stratification and Intensified Short-Course Multidrug Chemotherapy: Results of Trial ALL-REZ BFM 90
Gesche Tallen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004
W. A. Kamps et al.
LEUKEMIA (2010)
Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97
G. Escherich et al.
LEUKEMIA (2010)
IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL
R. P. Kuiper et al.
LEUKEMIA (2010)
Protein kinase networks regulating glucocorticoid-induced apoptosis of hematopoietic cancer cells: fundamental aspects and practical considerations
Shlomit Kfir-Erenfeld et al.
LEUKEMIA & LYMPHOMA (2010)
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
Gabriela Bindea et al.
BIOINFORMATICS (2009)
rtracklayer: an R package for interfacing with genome browsers
Michael Lawrence et al.
BIOINFORMATICS (2009)
Meayamycin inhibits pre-messenger RNA splicing and exhibits picomolar activity against multidrug-resistant cells
Brian J. Albert et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches
Mo Chen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Charles G. Mullighan et al.
NATURE (2007)
Glucocorticoid resistance in two key models of acute lymphoblastic leukemia occurs at the level of the glucocorticoid receptor
Stefan Schmidt et al.
FASEB JOURNAL (2006)
The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia
A Holleman et al.
BLOOD (2006)
Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy:: Results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Miinster Group 87
HG Einsiedel et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The human glucocorticoid receptor: One gene, multiple proteins and diverse responses
JG Zhou et al.
STEROIDS (2005)
Dexamethasone resistance in B-cell precursor childhood acute lymphoblastic leukemia occurs downstream of ligand-induced nuclear translocation of the glucocorticoid receptor
PS Bachmann et al.
BLOOD (2005)
Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment
A Holleman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Consequences of regulated pre-mRNA splicing in the immune system
KW Lynch
NATURE REVIEWS IMMUNOLOGY (2004)
Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia
A Holleman et al.
BLOOD (2003)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia
WJE Tissing et al.
LEUKEMIA (2003)